Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$255.56
▲ $2.28 (+0.90%) today
Markets closed · 3:48am ET

JNJ Coverage Page 90

4:01am ET
Health and Healthcare

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help…

Douglas A. McIntyre
6:56am ET
Investing

J&J’s Earnings Win Muted By Currency Impact (JNJ)

DJIA component Johnson & Johnson (NYSE: JNJ) has come out with earnings slightly ahead of estimates.  The medical and consumer products giant posted $1.15 EPS vs $1.11 estimates and revenues were down…

JNJ
Douglas A. McIntyre
6:39am ET
Investing

Top Analyst Downgrades (BKC, JNJ, LVLT, NETL)

These are the few top pre-market analyst downgrades or cautious research calls from Wall Street firms this Friday morning with about two hours until the market opens: Burger King (BKC) Cut to…

Douglas A. McIntyre